IMMX vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 25, 2026

IMMX

33.6
AI Score
VS
SYRE Wins

SYRE

46.9
AI Score

Investment Advisor Scores

IMMX

34score
Recommendation
SELL

SYRE

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IMMX SYRE Winner
Net Income -21.64M -155.20M IMMX
Operating Income -23.26M -209.56M IMMX
ROE -9.5% -21.7% IMMX
ROA -9.1% -20.0% IMMX
Total Assets 239.11M 777.78M SYRE
Cash 225.49M 85.72M IMMX
Current Ratio 25.13 13.25 IMMX

Relative Price Performance (Last 90 Days)

IMMX 1M: +59.7% · 3M: +55.0% SYRE 1M: +4.4% · 3M: +44.0%

Current Technical Phase

IMMX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.1% over 20 days), RSI 74

RSI (14): 74.0 · Price: $13.61

SYRE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.1% over 20 days), RSI 58

RSI (14): 58.1 · Price: $106.65

Fundamentals Snapshot

Metric IMMX SYRE
Market Cap
Forward P/E -15.1 -31.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -0.88 -1.92
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.